Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe disease
- 1 July 2006
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 149 (1), 89-97
- https://doi.org/10.1016/j.jpeds.2006.02.035
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Carbohydrate-remodelled acid α-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe miceBiochemical Journal, 2005
- Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trialNeuromuscular Disorders, 2005
- High-resolution Light Microscopy (HRLM) and Digital Analysis of Pompe Disease PathologyJournal of Histochemistry & Cytochemistry, 2005
- Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse modelGene Therapy, 2004
- Pompe disease in infants and childrenThe Journal of Pediatrics, 2004
- Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)The Journal of Pediatrics, 2004
- Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)The Journal of Pediatrics, 2004
- Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingEuropean Journal of Human Genetics, 1999
- Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail.Journal of Clinical Investigation, 1998
- Expression of the insulin-like growth factor-II/mannose-6-phosphate receptor in multiple human tissues during fetal life and early infancyJournal of Clinical Endocrinology & Metabolism, 1992